Pharmacodynamic study of chitosan in combination with salvianolic acid B in the treatment of CC14‐induced liver fibrosis in mice

Liver fibrosis is a chronic liver lesion caused by excessive deposition of the extracellular matrix after liver damage, resulting in fibrous scarring of liver tissue. The progression of liver fibrosis is partially influenced by the gut microbiota. Chitosan can play a therapeutic role in liver fibros...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and experimental pharmacology & physiology 2024-01, Vol.51 (1), p.17-29
Hauptverfasser:	Yao, Zhongwei, Du, Minshu, Wang, Yalu, Zhu, He, Shu, Luan, You, Xia, Wang, Jing
Format:	Artikel
Sprache:	eng
Schlagworte:	Acids Cell activation Chitosan combination Extracellular matrix Fibrosis Intestinal microflora Liver liver fibrosis Microbiota Microorganisms Pharmacodynamics salvianolic acid B Stellate cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!